Open AccessInteractions of manufactured silver nanoparticles of different sizes with normal human dermal fibroblasts
Author(s) -
Avalos Alicia,
Haza Ana I,
Mateo Diego,
Morales Paloma
Publication year - 2016
Publication title -
international wound journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.867
H-Index - 63
eISSN - 1742-481X
pISSN - 1742-4801
DOI - 10.1111/iwj.12244
Subject(s) - oxidative stress , toxicity , lactate dehydrogenase , reactive oxygen species , glutathione , cytotoxicity , superoxide dismutase , viability assay , silver nanoparticle , antioxidant , pharmacology , medicine , in vitro , mtt assay , biochemistry , chemistry , nanoparticle , nanotechnology , enzyme , materials science
Silver compounds have been used for their medicinal properties for centuries. At present, silver nanoparticles (AgNPs) are reemerging as a viable topical treatment option for infections encountered in burns, open wounds and chronic ulcers. This study evaluated the in vitro mechanisms of two different sizes of AgNPs (4·7 and 42 nm) toxicity in normal human dermal fibroblasts. The toxicity was evaluated by observing cell viability and oxidative stress parameters. In all toxicity endpoints studied ( MTT and lactate dehydrogenase assays), AgNPs of 4·7 nm were much more toxic than the large AgNPs (42 nm). The cytotoxicity of both AgNPs was greatly decreased by pre‐treatment with the antioxidant N‐acetyl‐L‐cysteine. The oxidative stress parameters showed significant increase in reactive oxygen species levels, depletion of glutathione level and slight, but not statistically significant inactivation of superoxide dismutase, suggesting generation of oxidative stress. Thus, AgNPs should be used with caution for the topical treatment of burns and wounds, medical devices etc, because their toxicity depends on the size, the smaller NPs being much more cytotoxic than the large.